Holt, 15,227 patient sleep study: 12% fewer cases [p=0.5] https://c19p.org/holtsl
copied to clipboard
Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK)
et al., Thorax, doi:10.1136/thoraxjnl-2021-217487
Prospective survey-based study with 15,227 people in the UK, showing reduced risk of COVID-19 cases with 8 hours sleep, with statistical significance when compared with ≥9 hours. NCT04330599. COVIDENCE UK.
|
risk of case, 12.3% lower, OR 0.88, p = 0.50, adjusted per study, fully adjusted, 8 hours vs. ≤6 hours, RR approximated with OR.
|
|
risk of case, 12.3% lower, OR 0.88, p = 0.33, adjusted per study, fully adjusted, 8 hours vs. 7 hours, RR approximated with OR.
|
|
risk of case, 22.5% lower, OR 0.78, p = 0.04, adjusted per study, fully adjusted, 8 hours vs. ≥9 hours, RR approximated with OR.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Holt et al., 3/30/2021, prospective, United Kingdom, Europe, peer-reviewed, 34 authors, study period 1 May, 2020 - 5 February, 2021, trial NCT04330599.
Contact:
a.martineau@qmul.ac.uk.
holt
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.